Professor
Graham CookeProfile page
Deputy Dean, Faculty of Medicine, Vice-Dean (Research)
Department of Infectious Disease - Faculty of Medicine
Orcid identifier0000-0001-6475-5056
- Deputy Dean, Faculty of Medicine, Vice-Dean (Research)Department of Infectious Disease - Faculty of Medicine
- Department of Infectious Disease, South Kensington Campus, United Kingdom
BIO
Professor Graham Cooke FMedSci is an NIHR Senior Investigator and Vice-Dean for research in the Faculty of Medicine. Based in the Department of Infectious Disease, he leads the Infection and Antimicrobial Resistance Theme of the Biomedical Research Centre.
He has led large interdisciplinary research programmes to inform efforts to eliminate viral hepatitis, particularly hepatitis C. These span studies of the mechanisms of host-viral interaction, investigation of disease burden, disease modelling, and clinical trials (e.g. PROLIFICA, STOPHCV consortia, STOPHCV-1 trial). He currently leads the SEARCH collaboration conducting strategic treatment trials for hepatitis C in Vietnam (in collaboration with OUCRU and MRC Clinical Trials Unit) and the Lancet journals Commission on accelerating the elimination of viral hepatitis.
In response to COVID19, he co-ordinated the COVID theme of the NIHR Biomedical Research Centre at Imperial, was a member of the WHO COVID-19 treatment guidelines group and led clinical development of the COVIDnudge diagnostic. He is a PI for the REACT programme which has recruited over 3 million consented participants to self-testing studies for COVID19 and is now providing a platform for investigation of other diseases, particularly dementia
He is active in promoting access to medicine and patient safety. Since 2015 , he has been a member of the WHO Committee on the Selection and Use of Essential Medicines, serving as Chair from 2019-23. The group was responsible for updating and maintaining the WHO Essential Medicines List (EML) and developed the AWaRe index as a tool for antimicrobial stewardship, now adopted in national policies worldwide. For the Infected Blood Inquiry (2019-24) ,he was convenor of the Hepatitis Expert Group. He is a non-executive director and deputy Chair of the board of the MHRA, serving as interim chair from 2023-5.
Funding: NIHR, Wellcome Trust, UKRI, DHSC, Médecins sans Frontières, BRC Imperial College, Open Philanthropy
Follow on twitter/bluesky: @grahamscooke
Clinical
Working across Imperial College NHS Trust and Chelsea and Westminster NHS Foundation Trust in HIV and ID services. Clinical enquiries should be made to 0203 312 7719.
He has led large interdisciplinary research programmes to inform efforts to eliminate viral hepatitis, particularly hepatitis C. These span studies of the mechanisms of host-viral interaction, investigation of disease burden, disease modelling, and clinical trials (e.g. PROLIFICA, STOPHCV consortia, STOPHCV-1 trial). He currently leads the SEARCH collaboration conducting strategic treatment trials for hepatitis C in Vietnam (in collaboration with OUCRU and MRC Clinical Trials Unit) and the Lancet journals Commission on accelerating the elimination of viral hepatitis.
In response to COVID19, he co-ordinated the COVID theme of the NIHR Biomedical Research Centre at Imperial, was a member of the WHO COVID-19 treatment guidelines group and led clinical development of the COVIDnudge diagnostic. He is a PI for the REACT programme which has recruited over 3 million consented participants to self-testing studies for COVID19 and is now providing a platform for investigation of other diseases, particularly dementia
He is active in promoting access to medicine and patient safety. Since 2015 , he has been a member of the WHO Committee on the Selection and Use of Essential Medicines, serving as Chair from 2019-23. The group was responsible for updating and maintaining the WHO Essential Medicines List (EML) and developed the AWaRe index as a tool for antimicrobial stewardship, now adopted in national policies worldwide. For the Infected Blood Inquiry (2019-24) ,he was convenor of the Hepatitis Expert Group. He is a non-executive director and deputy Chair of the board of the MHRA, serving as interim chair from 2023-5.
Funding: NIHR, Wellcome Trust, UKRI, DHSC, Médecins sans Frontières, BRC Imperial College, Open Philanthropy
Follow on twitter/bluesky: @grahamscooke
Clinical
Working across Imperial College NHS Trust and Chelsea and Westminster NHS Foundation Trust in HIV and ID services. Clinical enquiries should be made to 0203 312 7719.
FACULTY
- Faculty of Medicine
POSITION NAME
- Deputy Dean, Faculty of Medicine, Vice-Dean (Resea